These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7418276)

  • 21. Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders.
    Nishijima S; Sugaya K; Fukuda T; Miyazato M; Ashimine S; Ogawa Y
    Int J Urol; 2006 Dec; 13(12):1479-83. PubMed ID: 17118021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. II. Chief peptide constituents of the faction.
    Klein A; Sarnecka-Keller M; Hanicki Z
    Clin Chim Acta; 1978 Nov; 90(1):7-11. PubMed ID: 719891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and characterization of polyamides containing unnatural amino acids.
    Guinn RM; Margot AO; Taylor JR; Schumacher M; Clark DS; Blanch HW
    Biopolymers; 1995 May; 35(5):503-12. PubMed ID: 7766820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
    Wafford KA; Kathoria M; Bain CJ; Marshall G; Le Bourdellès B; Kemp JA; Whiting PJ
    Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apparent free amino acids in deproteinized plasma of normal and uremic persons.
    SALISBURY PF; DUNN MS; MURPHY EA
    J Clin Invest; 1957 Aug; 36(8):1227-32. PubMed ID: 13463085
    [No Abstract]   [Full Text] [Related]  

  • 28. Bipolar mania and plasma amino acids: increased levels of glycine.
    Hoekstra R; Fekkes D; Loonen AJ; Pepplinkhuizen L; Tuinier S; Verhoeven WM
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):71-7. PubMed ID: 16023835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.
    Patel SR; Ke HQ; Vanholder R; Koenig RJ; Hsu CH
    J Clin Invest; 1995 Jul; 96(1):50-9. PubMed ID: 7615822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study.
    Qureshi AI; Ali Z; Suri MF; Shuaib A; Baker G; Todd K; Guterman LR; Hopkins LN
    Crit Care Med; 2003 May; 31(5):1482-9. PubMed ID: 12771622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
    Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
    Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
    J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
    Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of free amino acids with caries experience and mutans streptococci levels in whole saliva of children with early childhood caries.
    Fonteles CS; Guerra MH; Ribeiro TR; Mendonça DN; de Carvalho CB; Monteiro AJ; Toyama DO; Toyama MH; Fonteles MC
    Arch Oral Biol; 2009 Jan; 54(1):80-5. PubMed ID: 18774124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ionizable chromophoric reagent for the analysis of primary amine-containing drugs by capillary electrophoresis.
    Lin FM; Kou HS; Wu SM; Chen SH; Kwan AL; Wu HL
    Electrophoresis; 2005 Feb; 26(3):621-6. PubMed ID: 15690434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New active paclitaxel amino acids derivatives with improved water solubility.
    Paradis R; Pagé M
    Anticancer Res; 1998; 18(4A):2711-6. PubMed ID: 9703933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial purification and characterization of the drug-binding-defect inducer in uremia.
    Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
    J Lab Clin Med; 1981 Jan; 97(1):72-81. PubMed ID: 7452082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of tissue plasminogen activator specificity using peptidyl fluorogenic substrates.
    Butenas S; Kalafatis M; Mann KG
    Biochemistry; 1997 Feb; 36(8):2123-31. PubMed ID: 9047311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds.
    Schmieden V; Betz H
    Mol Pharmacol; 1995 Nov; 48(5):919-27. PubMed ID: 7476923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.